Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

pengarang

Matthias Van Haele

Iván M Moya

Ruchan Karaman

Olivier Govaere

Chris Verslype

Diethard Monbaliu

Tania A Roskams

diterbitkan dalam: International Journal of Molecular Sciences

tanggal publikasi: 2019-02-01

bahasa: Inggris

subyek utama: heterogeneity, kanker hati

Cites articles 40

Date

Judul

Pengarang

2018-01-05

Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.

Randy L Johnson
2018-05-09

cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation

Kathryn J Fowler, Irene Oi-lin Ng, Wilson Tsui, Jessica Zucman-Rossi, Tania Roskams, Gregory J Gores, Romil Saxena, David S Klimstra, Elizabeth M. Brunt, Michiie Sakamoto
2018-04-14

Crosstalk between YAP/TAZ and Notch Signaling
2018-09-11

The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors

Thijs J Hagenbeek, Noelyn M Kljavin, Ho-June Lee, Christiaan Klijn, Allen G Cai, Naiying Yang, Kevin Walsh, Zhixiang Zhang, Anwesha Dey
2018-10-01

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017-01-01

The epidemiology of non-alcoholic fatty liver disease

Stefano Bellentani
2017-01-23

Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity

Josep M. Llovet, Agrin Moeini, Genis Camprecios, Ashley E Stueck, Laura Torrens, Augusto Villanueva
2017-05-19

Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification

Sandrine Imbeaud, Eric Letouzé, Camille Laurent, Jean Charles Nault, Jessica Zucman-Rossi, Paulette Bioulac-Sage
2017-06-23

The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas

Kyoungbun Lee
2017-08-07

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.

Olivier Govaere, Jasper Wouters, Emma Scott, Quentin M Anstee
2017-09-20

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Elisabetta Bugianesi, Mohammed Eslam
2016-03-08

Notch Signaling Coordinates Progenitor Cell-Mediated Biliary Regeneration Following Partial Hepatectomy

Bin Zhou, Chuanyong Guo, Kan Chen, Weiqi Dai, Yujing Xia, Yuanyuan Zheng, Wenxia Lu, Rong Zhu, Miao Shen, Junshan Wang
2016-06-01

YAP/TAZ at the Roots of Cancer

Michelangelo Cordenonsi
2016-11-18

Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis
2016-12-19

Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis

Dean Yimlamai, Fernando Camargo
2015-02-03

Functional and clinical evidence that TAZ is a candidate oncogene in hepatocellular carcinoma
2015-04-02

Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells

Dimitris G Placantonakis, Alka Mansukhani
2015-03-12

Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma
2015-09-29

An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression
2015-10-05

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

Toshiro Moroishi, Carsten G Hansen, Georg Halder
2014-04-26

Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment.

Kwhanmien Kim, Sanghoon Jheon, Choon-Taek Lee
2014-04-22

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

Su-Xia Han
2014-07-07

YAP activation is an early event and a potential therapeutic target in liver cancer development

Massimo Roncalli, Luca Di Tommaso, Silvia Giordano, Amedeo Columbano, Andrea Perra, Marta Anna Kowalik, Giovanna Maria Ledda-Columbano, Maria Maddalena Angioni
2014-09-23

Intratumor heterogeneity in hepatocellular carcinoma

Mathias Heikenwalder, Holger Moch
2013-02-04

Emerging roles of TEAD transcription factors and its coactivators in cancers
2013-03-07

The Hippo pathway and human cancer

Kieran Harvey, David M Thomas
2013-08-19

Keratin 19: a key role player in the invasion of human hepatocellular carcinomas

Leo A van Grunsven, Jasper Wouters, Olivier Govaere, Joery De Kock, Jacques Pirenne, Tania Roskams
2013-09-24

Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma

Hyunki Kim, Young Nyun Park
2012-06-13

Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.

Laura Rubbia-Brandt
2012-06-19

A morpho-molecular prognostic model for hepatocellular carcinoma
2012-09-14

SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas
2011-05-13

Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice

Monica Pibiri, Silvia Giordano, Amedeo Columbano, Giovanna M Ledda-Columbano, Andrea Perra, Marta Anna Kowalik

Artikel - wd:Q64273870

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut